Issue : The Pharmaceutical Journal, online
Sort by: Newest first Oldest first A-Z Z-A
-
All healthcare professionals responsible for deprescribing, say network co-chairs
Deprescribing is not just the responsibility of pharmacists, co-chairs for the English Deprescribing Network (EDeN) have stressed.
-
Cost of medicines prescribed in hospitals and primary care increases by 4% in one year
The cost of medicines prescribed by hospitals and in primary care has increased by 4% to of £18.9bn in 2018/2019.
-
Everything you need to know about foundation training Subscription
A closer look at the progress made so far on introducing a nationwide foundation training scheme.
-
More funding needed to meet 'NHS long-term plan', pharmacy leads warn
Pharmacy leads responsible for an area that covers 1.5 million people have warned that “urgent action” to increase pharmacy training funds is needed if the pharmacy workforce is to deliver on the ‘NHS long-term plan’.
-
GPs to vote on giving pharmacists power to substitute medicines during shortages
GPs are set to vote on whether pharmacists should be “responsible for identifying appropriate and available alternatives” when medicines are in short supply.
-
Rapid tests for strep A not recommended for sore throat by NICE
Rapid tests for group A streptococcal infections have not been recommended for routine adoption for people with a sore throat.
-
Hepatitis A and B vaccine added to export ban list
The hepatitis A and B vaccine has been added to the list of medicines that cannot be parallel exported from the UK.
-
GPhC raises concerns after fitness-to-practise complaints reach record high
The General Pharmaceutical Council has raised concerns over a 7% increase in the number of fitness-to-practise complaints brought to the regulator between July 2019 and September 2019.
-
RPS election manifesto calls for investment in workforce development
The Royal Pharmaceutical Society is asking candidates in the upcoming general election to pledge their support for pharmacy.
-
First patient in Wales to begin CAR-T personalised therapy
A patient in Wales will become the first in the country to start chimeric antigen receptor T-cell therapy after other treatments for his lymphoma were unsuccessful.
Show 10 per page20 per page50 per page
